Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kretschmer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 27, 2017
Antibody Isotypes for Tumor ImmunotherapyAnna Kretschmer, Ralf Schwanbeck, Thomas Valerius, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2019
CAR-Expressing Natural Killer Cells for Cancer RetargetingStephan Kloess, Anna Kretschmer, Lilly Stahl, et al.
Experimental Animals|August 7, 2018
Effect of combined sublethal X-ray irradiation and cyclosporine A treatment in NOD scid gamma (NSG) miceLia Walcher, Claudia Müller, Nadja Hilger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2017
Monoclonal Antibodies against Epidermal Growth Factor Receptor Acquire an Ability To Kill Tumor Cells through Complement Activation by Mutations That Selectively Facilitate the Hexamerization of IgG on Opsonized CellsAnnalina Tammen, Stefanie Derer, Ralf Schwanbeck, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 27, 2017
An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated CytotoxicityTim Wirt, Sophia Rosskopf, Thies Rösner, et al.
Frontiers in Immunology|November 9, 2018
Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid LeukemiaNadja Hilger, Claudia Mueller, Lilly Stahl, et al.
British Journal of Haematology|February 23, 2018
New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodiesSaskia Meyer, Mitchell Evers, Johannes H M Jansen, et al.
Cancer Research|December 5, 2015
An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In VivoStefan Lohse, Saskia Meyer, Laura A P M Meulenbroek, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 27, 2017
Antibody Isotypes for Tumor ImmunotherapyAnna Kretschmer, Ralf Schwanbeck, Thomas Valerius, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2019
CAR-Expressing Natural Killer Cells for Cancer RetargetingStephan Kloess, Anna Kretschmer, Lilly Stahl, et al.
Experimental Animals|August 7, 2018
Effect of combined sublethal X-ray irradiation and cyclosporine A treatment in NOD scid gamma (NSG) miceLia Walcher, Claudia Müller, Nadja Hilger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2017
Monoclonal Antibodies against Epidermal Growth Factor Receptor Acquire an Ability To Kill Tumor Cells through Complement Activation by Mutations That Selectively Facilitate the Hexamerization of IgG on Opsonized CellsAnnalina Tammen, Stefanie Derer, Ralf Schwanbeck, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 27, 2017
An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated CytotoxicityTim Wirt, Sophia Rosskopf, Thies Rösner, et al.
Frontiers in Immunology|November 9, 2018
Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid LeukemiaNadja Hilger, Claudia Mueller, Lilly Stahl, et al.
British Journal of Haematology|February 23, 2018
New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodiesSaskia Meyer, Mitchell Evers, Johannes H M Jansen, et al.
Cancer Research|December 5, 2015
An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In VivoStefan Lohse, Saskia Meyer, Laura A P M Meulenbroek, et al.
Pageof 1